In July this year, Trxade completed its business combination with Scienture in a $103-million deal. Under the all-stock transaction, the company acquired all of Scienture’s assets in exchange for shares of Trxade’s stock.
Scienture, LLC is a New York-based pharmaceutical company with strategic capabilities across R&D, manufacturing, sales & marketing, and commercial operations. Last month, Narasimhan Mani was appointed as Scienture’s president. Rahul Surana was promoted to executive vice president and chief operating officer of the company.
Integra Pharma Solutions is a pharmaceutical supplier with expertise in product distribution across all key healthcare markets including government organizations, hospitals, clinics, and independent pharmacies.